ReviewChinese medical journal2026

Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026).

Zucheng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.